The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Perfluorooctanoate and Perfluorooctanesulfonate Plasma Levels and Risk of Cancer in the General Danish Population
Abstract
Perfluorooctanoate and perfluorooctanesulfonate are used in many industrial products and have been widely detected in human blood. Both chemicals are associated with tumor development in animal studies, but data on carcinogenic potential in humans are sparse. We investigated the association between plasma levels of perfluorooctanoate and perfluorooctanesulfonate and cancer risk within a prospective Danish cohort of participants with no previous cancer diagnosis at enrollment. From enrollment, between December 1, 1993, and May 31, 1997, and through July 1, 2006, we identified 713 participants with prostate cancer, 332 with bladder cancer, 128 with pancreatic cancer, and 67 with liver cancer in the entire cohort and we selected a comparison subcohort of 772. Plasma concentrations of perfluorooctanoate and perfluorooctanesulfonate were measured in each participant by use of high-pressure liquid chromatography coupled to tandem mass spectrometry. We found no clear differences in incidence rate ratios for these cancers in relation to plasma concentrations of perfluorooctanoate or perfluorooctanesulfonate. A 30%-40% increase in risk estimates for prostate cancer was observed for the three upper quartiles of perfluorooctanesulfonate concentration compared with the lowest quartile (eg, for the lowest vs the fourth quartile, incidence rate ratio = 1.38, 95% confidence interval = 0.99 to 1.93). Plasma concentrations of perfluorooctanoate and perfluorooctanesulfonate in the general Danish population appear not to be associated with risk of prostate, bladder, pancreatic, or liver cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Only studies made by Eriksen et al. and Hardell et al. showed statistical significant association between PFC concentration and prostate cancer [17, 20].”
From Overview of emerging contaminants and associated human health effects (2015) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885
Estimation of Average Concentration in the Presence of Nondetectable Values
Hornung, R. W., & Reed, L. D. (1990) · Applied Occupational and Environmental Hygiene · doi:10.1080/1047322x.1990.10389587 · Cited by 3,495
Global Distribution of Perfluorooctane Sulfonate in Wildlife
Giesy, J. P., & Kannan, K. (2001) · Environmental Science & Technology · doi:10.1021/es001834k · Cited by 2,750
Olsen, G. W., Burris, J. M., Ehresman, D. J., Froehlich, J. W., Seacat, A. M., Butenhoff, J. L., & Zobel, L. R. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10009 · Cited by 2,049
Dose-Response and Trend Analysis in Epidemiology
Greenland, S. (1995) · Epidemiology · doi:10.1097/00001648-199507000-00005 · Cited by 1,086
Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries
Kannan, K., Corsolini, S., Falandysz, J., Fillmann, G., Kumar, K. S., Loganathan, B. G., Mohd, M. A., Olivero, J., Wouwe, N. V., Yang, J. H., et al. (2004) · Environmental Science & Technology · doi:10.1021/es0493446 · Cited by 1,056
The toxicology of perfluorooctanoate
Kennedy, G. L., Butenhoff, J. L., Olsen, G. W., O'Connor, J. C., Seacat, A. M., Perkins, R. G., Biegel, L. B., Murphy, S. R., & Farrar, D. G. (2004) · Critical Reviews in Toxicology · doi:10.1080/10408440490464705 · Cited by 742
Analysis of Case-Cohort Designs
Barlow, W. E., Ichikawa, L., Rosner, D., & Izumi, S. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00102-x · Cited by 682
Perfluorinated Chemicals and Fetal Growth: A Study within the Danish National Birth Cohort
Fei, C., McLaughlin, J. K., Tarone, R. E., & Olsen, J. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10506 · Cited by 636
Self-citationTjønneland, A. M., Olsen, A., Boll, K., Stripp, C., Christensen, J., Engholm, G., & Overvad, K. (2007) · Scandinavian Journal of Public Health · doi:10.1080/14034940601047986 · Cited by 601
Self-citationRobust Variance Estimation for the Case-Cohort Design
Barlow, W. E. (1994) · Biometrics · doi:10.2307/2533444 · Cited by 542
Olsen, G. W., Burris, J. M., Burlew, M., & Mandel, J. H. (2003) · Journal of Occupational and Environmental Medicine · doi:10.1097/01.jom.0000052958.59271.10 · Cited by 362
Emmett, E. A., Shofer, F. S., Zhang, H., Freeman, D. W., Desai, C. S., & Shaw, L. M. J. (2006) · Journal of Occupational and Environmental Medicine · doi:10.1097/01.jom.0000232486.07658.74 · Cited by 357
Ehresman, D. J., Froehlich, J. W., Olsen, G. W., Chang, S., & Butenhoff, J. L. (2006) · Environmental Research · doi:10.1016/j.envres.2006.06.008 · Cited by 353
Perfluorochemicals in Pooled Serum Samples from United States Residents in 2001 and 2002
Calafat, A. M., Kuklenyik, Z., Caudill, S. P., Reidy, J. A., & Needham, L. L. (2006) · Environmental Science & Technology · doi:10.1021/es0517973 · Cited by 219
Butenhoff, J. L., Olsen, G. W., & Pfahles-Hutchens, A. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.9060 · Cited by 201
Mortality Among Employees of a Perfluorooctanoic Acid Production Plant
Gilliland, F. D., & Mandel, J. S. (1993) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-199309000-00020 · Cited by 183
Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility
Alexander, B. H., Olsen, G. W., Burris, J. M., Mandel, J. H., & Mandel, J. S. (2003) · Occupational and Environmental Medicine · doi:10.1136/oem.60.10.722 · Cited by 179
Perfluorinated chemicals in selected residents of the American continent
Calafat, A. M., Needham, L. L., Kuklenyik, Z., Reidy, J. A., Tully, J. S., Aguilar-Villalobos, M., & Naeher, L. P. (2005) · Chemosphere · doi:10.1016/j.chemosphere.2005.08.028 · Cited by 166
Midasch, O., Schettgen, T., & Angerer, J. (2006) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2006.06.002 · Cited by 115
Storm, H. H. (1991) · PubMed · Cited by 106
Bladder Cancer in Perfluorooctanesulfonyl Fluoride Manufacturing Workers
Alexander, B. H., & Olsen, G. W. (2007) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.01.036 · Cited by 104
Rothman, K. (2002) · Medical Entomology and Zoology · Cited by 36
Peroxisomal Enzymes and 8‐Hydroxydeoxyguanosine in Rat Liver Treated with Perfluorooctanoic Acid
Abdellatif, A. G., Al-tonsy, A. H., Awad, M., Roberfroid, M., & Khan, M. N. (2003) · Disease Markers · doi:10.1155/2003/135859 · Cited by 23
Rothman, K. J., Huybrechts, K. F., & Murray, E. J. (2024) · doi:10.1093/oso/9780197751541.001.0001 · Cited by 12
Research works printed but not linked: 1
- 2006, 63, 490
Cited by
Sorted by citations
Sunderland, E. M., Hu, X. C., Dassuncao, C., Tokranov, A. K., Wagner, C. C., & Allen, J. G. (2019) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/s41370-018-0094-1 · Cited by 2,786
Barry, V., Winquist, A. G., & Steenland, K. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1306615 · Cited by 824
“Eriksen et al. (2009) enrolled 57,053 cancer-free Danish adults 50–65 years of age; they measured PFOA plasma concentrations during enrollment and followed participants for approximately 10 years for incident prostate, pancreas, liver, and bladder cancers.”
BackgroundEpidemiologic Evidence on the Health Effects of Perfluorooctanoic Acid (PFOA)
Steenland, K., Fletcher, T., & Savitz, D. A. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901827 · Cited by 660
“Another nonoccupational cohort, with much lower exposure levels, has been followed for cancer in Denmark, with no significant excesses observed (Eriksen et al. 2009).”
Post, G. B., Cohn, P. D., & Cooper, K. R. (2012) · Environmental Research · doi:10.1016/j.envres.2012.03.007 · Cited by 639
Podder, A., Sadmani, A. H. M. A., Reinhart, D., Chang, N.-B., & Goel, R. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.126361 · Cited by 623
Metadata
- Authors
- Eriksen, K. T., Sorensen, M., McLaughlin, J. K., Lipworth, L., Tjonneland, A., Overvad, K., & Raaschou-Nielsen, O.
- Affiliations
- Aarhus University Hospital (DK)
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-04-07
- Volume
- 101
- Issue
- 8
- Pages
- 605-609
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2098197528
- Cited by
- 150
- References
- 25
- Citations by year
- 2026: 13 · 2025: 15 · 2024: 17 · 2023: 12 · 2022: 14 · 2021: 11 · 2020: 7 · 2019: 2 · 2018: 6 · 2017: 5 · 2016: 3 · 2015: 8 · 2014: 11 · 2013: 10 · 2012: 7
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JNCI Journal of the National Cancer Institute (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- 3M
- Topics
- Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
- Physical Sciences › Chemistry › Organic Chemistry › Fluorine in Organic Chemistry
- Keywords
- perfluorooctanoic acid, PFOS, perfluorinated compounds, plasma concentration, cancer risk, prostate cancer, bladder cancer, pancreatic cancer, liver cancer, prospective cohort, carcinogenicity, biomarkers of exposure
- MeSH terms
- Aged, Analysis of Variance, Urinary Bladder Neoplasms, Caprylates, Chromatography, High Pressure Liquid, Denmark, Environmental Pollutants, Female, Fluorocarbons, Humans, Liver Neoplasms, Male, Middle Aged, Neoplasms, Pancreatic Neoplasms, Prospective Studies, Prostatic Neoplasms, Risk Factors, Cohort Studies, Incidence, Odds Ratio, Alkanesulfonic Acids, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
